These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 28460594)
1. A trivalent, inactivated influenza vaccine (Vaxigrip®): summary of almost 50 years of experience and more than 1.8 billion doses distributed in over 120 countries. Haugh M; Gresset-Bourgeois V; Macabeo B; Woods A; Samson SI Expert Rev Vaccines; 2017 Jun; 16(6):545-564. PubMed ID: 28460594 [TBL] [Abstract][Full Text] [Related]
8. Safety and immunogenicity of a quadrivalent inactivated influenza vaccine in adults. Pépin S; Donazzolo Y; Jambrecina A; Salamand C; Saville M Vaccine; 2013 Nov; 31(47):5572-8. PubMed ID: 24016810 [TBL] [Abstract][Full Text] [Related]
9. Enhanced passive safety surveillance of three marketed influenza vaccines in the UK and the Republic of Ireland during the 2017/18 season. Gandhi-Banga S; Chabanon AL; Eymin C; Caroe T; Butler K; Moureau A Hum Vaccin Immunother; 2019; 15(9):2154-2158. PubMed ID: 30897026 [TBL] [Abstract][Full Text] [Related]
10. Immunogenicity and safety of an inactivated quadrivalent influenza vaccine in healthy adults: a phase II, open-label, uncontrolled trial in Japan. Tsurudome Y; Kimachi K; Okada Y; Matsuura K; Ooyama Y; Ibaragi K; Kino Y; Ueda K Microbiol Immunol; 2015 Oct; 59(10):597-604. PubMed ID: 26272602 [TBL] [Abstract][Full Text] [Related]
11. Safety and immunogenicity of high-dose trivalent inactivated influenza vaccine in adults 50-64 years of age. DiazGranados CA; Saway W; Gouaux J; Baron M; Baker J; Denis M; Jordanov E; Landolfi V; Yau E Vaccine; 2015 Dec; 33(51):7188-7193. PubMed ID: 26555348 [TBL] [Abstract][Full Text] [Related]
12. Immunogenicity and safety of a quadrivalent inactivated influenza vaccine compared with two trivalent inactivated influenza vaccines containing alternate B strains in adults: A phase 3, randomized noninferiority study. Treanor JT; Albano FR; Sawlwin DC; Graves Jones A; Airey J; Formica N; Matassa V; Leong J Vaccine; 2017 Apr; 35(15):1856-1864. PubMed ID: 28302411 [TBL] [Abstract][Full Text] [Related]